BioLife

BioLife

Created using Figma
BioLife digitizes assets and handles private records for patients, investors and owners of global biomedical resources. The BioLife digital ecosystem integrates the world’s major life science resources to underpin lifetime patient care and ensure global liquidity for the bioscience industry.
TGE
Nov 28, 2018
Dec 4, 2018
100% completed
Raised funds - no Data
past
Token Details
Ticker
BIOT
Token Distribution
Sales - 75%
Team - 12%
Reserve - 5%
Marketing - 4%
Advisors and Asset Providers - 4%
Additional Details
Categories
Platform

About BioLife

BioLife will increase the visible value of Bioscience resources worldwide by combining 3 automated systems for messaging, transaction processing and smart contracts into a digital ecosystem for the Bioscience industry.

BioLife  will  build  a  global  high-end  biomedical  resources  DLT platform  for  products,  services  and  data  to  provide  safe, private, reliable,  efficient  and  economical  service access  for biomedical  resource  owners,  patients  and  investors.

A  consortium  chain  based  on  ACChain,  BioLife  is  an  on-chain asset  digitization  and  private  handler  for  patients,  investors and owners  of  global  biomedical  resources.  BioLife’s  digital ecosystem  is  a  distributed,  adaptive,  open-source,  peer  to peer  system.  Its blockchain  properties  of  self-organization, scalability,  interoperability  and  resilience  were  inspired by  the  very  natural  ecosystems from  which  Swiss  Serolab derives  its  health  care  solutions.  Distribution,  circulation and  service  placement  are  the  three  basic applications  of the  BioLife  digital  ecosystem.

The BioLife Service Platform will provide digital portals for pharmaceutical companies, biomedical institutions and equipment manufacturers and use blockchain technology to record the entire process of the biomedical services supply chain, treatment processes and results. BioLife’s adoption of DLT as its technology backbone will introduce the following benefits to all areas of the biomedical services sector that are impacted by BioLife Data: heightened security and resistance to tampering, protection of personally identifiable information and other elements of privacy (including protection against data scrapes), elimination of any single point of failure and disintermediation of third parties (thereby reducing transaction times and eliminating third party transaction fees).

Features

In the future, BioLife will be extended to smartwear for the daily collection of physical health data. It can achieve realtime monitoring and early warning of a patient’s physical health through artificial intelligence, machine learning and big data technology. At the same time, BioLife will also head in the direction of biomedical science and research, providing a large amount of sample data for scientific research institutions. This will establish a shared data platform among scientific research institutions, recording biomedical scientific research results to ensure the clarity of ownership and accurate return of scientific research results to reduce R&D duplication and to enjoy the fruitful results. BioLife is aiming to promote the progress and sustainable development of life science and technology.

BioLife Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

William Liu
Founder & CEO
unverified

3 ICO

$200 000

Genevieve Leveille
Founder & Venture Partner
unverified
Serena Yin
Founder & COO
unverified
Hannah Potter
Design Consultancy
unverified
Larry Bates
CIO
unverified
Tao Meng
Chief Expert of Artificial Intelligence
unverified
Kejia Wang
Team Member
unverified
Wei Huang
- Chief Expert of Big Data Operations
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

85 ICOs

$194 839 197

Simon Cocking
Advisor
unverified
Leonidas Katsaitis
Advisor
unverified
Nakul Correa
Advisor
unverified
Leon Hill
Advisor
unverified
Matthew Gardiner
Advisor
unverified

BioLife Last News

  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.